Evidence map›Paper›PMID 42455667›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

Hydrodynamic dispersion drives viral-cellular contact for gene delivery in porous media.

Vishal Srikanth, Micah Mallory, Andrew J Ulmer, Wesley R Legant, Andrey V Kuznetsov, Yevgeny Brudno

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Hydrodynamic dispersion drives viral-cellular contact for gene delivery in porous media.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Vishal SrikanthDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.ORCID 0000-0002-2521-3323
Micah MalloryLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695.ORCID 0000-0001-5905-102X
Andrew J UlmerLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695.
Wesley R LegantLampe Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill and North Carolina State University, Raleigh, NC 27695.ORCID 0000-0003-1827-5371
Andrey V KuznetsovDepartment of Mechanical and Aerospace Engineering, North Carolina State University, Raleigh, NC 27695.ORCID 0000-0002-2692-6907
Yevgeny BrudnoDivision of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599.ORCID 0000-0003-2963-3293

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Substrate Mediated siRNA Delivery from Scaffolds to Promote Wound RepairR01EB019409 · NIBIB · VANDERBILT UNIVERSITY · PI Craig Lewis Duvall · 2014 to 2026
$4.0M
Biomaterial Scaffolds for Ex Vivo and In Situ CAR-T Cell ProductionR37CA260223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yevgeny Brudno · 2021 to 2026
$2.5M
Next-generation imaging to interrogate biological systems across time and spaceR35GM158040 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEGANT, WESLEY R. · 2025 to 2025
$2.3M
MASTER Scaffolds for Rapid, Single-Step Manufacture and Prototyping of CAR-T cellsR33CA281875 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Yevgeny Brudno · 2023 to 2026
$1.3M
NC State Chemistry of Life Training Program (CLTP)T32GM141887 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI PIERCE, JOSHUA G. · 2021 to 2025
$1.3M
HHS | National Institutes of Health (NIH) R01EB019409HHS | National Institutes of Health (NIH) R33CA281875HHS | National Institutes of Health (NIH) R37CA260223National Science Foundation (NSF) DMS-2451660NCI NIH HHS P30 CA016086NCI NIH HHS R33 CA281875NCI NIH HHS R37 CA260223NIBIB NIH HHS R01 EB019409NIGMS NIH HHS R35 GM158040NIGMS NIH HHS T32 GM141887
6 · The paper itself

Abstract

Reactive biological processes often hinge on rare collisions between particles whose transport is governed by disparate advective, diffusive, and sedimentary mechanisms. Biological cell-virus encounters offer a uniquely quantifiable instance of this general problem: collisions between particles whose transport is governed by entirely different physical mechanisms, yet whose interactions determine system-level function. In stagnant liquids, nanoscale viral vectors explore space only via slow Brownian diffusion, whereas microscale cells rapidly sediment, producing species separation that suppresses virus-cell interfacial interactions. Here we show that liquid absorption into a dry, macroporous sponge enhances viral-cellular interactions by shifting the system into an advection-dispersion regime that circumvents this sedimentation-diffusion limit. By integrating experimental results with a multiscale simulation model, we demonstrate that the tortuous sponge porosity converts capillary-driven flow into convective mixing, driving orders-of-magnitude increases in viral-cellular collision rates. Coupling these dispersive transport dynamics with a probabilistic capture model reveals that hydrodynamic dispersion accounts for the multifold enhancement in viral-cellular transduction efficiency observed in porous sponges. These results provide a quantitative framework for emergent collision dynamics in complex porous media and establish a generalizable strategy to optimize active transport in spatiotemporally heterogeneous biological systems.

Indexed as

Gene Transfer TechniquesHydrodynamicsAnimalsDiffusionHumansPorositybiomaterialscellular reprogrammingcomputational fluid dynamicsgene therapy

Identifiers

PMID42455667
PMCPMC13389550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.